ArticleJournal of experimental & clinical cancer research : CR2017

ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway.

Juntang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.